{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:42:39Z","timestamp":1784288559557,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Research Council of the Islamic Republic of Iran","award":["121"],"award-info":[{"award-number":["121"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.clinbiochem.2014.03.004","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T01:46:40Z","timestamp":1395452800000},"page":"1239-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study"],"prefix":"10.1016","volume":"47","author":[{"given":"Amirahmad","family":"Nejat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadhassan","family":"Mirbolouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mohebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Hasheminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Tohidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Saadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0005","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability, and the contribution of risk factors: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2261-7-32","article-title":"Prevalence of coronary artery disease risk factors in iran: a population based survey","volume":"7","author":"Hatmi","year":"2007","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.hjr.0000216552.81882.ca","article-title":"Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran lipid and glucose study","volume":"13","author":"Hadaegh","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1023606524944","article-title":"Serum lipid levels in an iranian adults population: Tehran lipid and glucose study","volume":"18","author":"Azizi","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0025","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9149(76)90061-8","article-title":"A general cardiovascular risk profile: the framingham study","volume":"38","author":"Kannel","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/fampra\/cmi092","article-title":"Consequences of using different methods to assess cardiovascular risk in primary care","volume":"23","author":"Fornasini","year":"2006","journal-title":"Fam Pract"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0045","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0002-8703(94)90393-X","article-title":"Long-term intraindividual cholesterol variability: natural course and adverse impact on morbidity and mortality\u2014the Framingham study","volume":"127","author":"Kreger","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12325-010-0019-4","article-title":"Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events","volume":"27","author":"Laitinen","year":"2010","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0055","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1210\/jc.2006-2267","article-title":"Rate of change and instability in body mass index, insulin resistance, and lipid metabolism as predictors of atherosclerotic vascular disease","volume":"92","author":"Christen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ahj.2005.12.007","article-title":"The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events","volume":"151","author":"Koro","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-147-6-200709180-00007","article-title":"Changes in triglyceride levels and risk for coronary heart disease in young men","volume":"147","author":"Tirosh","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-6215-10-5","article-title":"Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase ii","volume":"10","author":"Azizi","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0075","doi-asserted-by":"crossref","first-page":"628-36 e1","DOI":"10.1016\/j.amepre.2010.03.003","article-title":"Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community","volume":"38","author":"Harati","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0080","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s000380200008","article-title":"Cardiovascular risk factors in an iranian urban population: Tehran lipid and glucose study (phase 1)","volume":"47","author":"Azizi","year":"2002","journal-title":"Soz Praventivmed"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1476-511X-9-52","article-title":"A modified formula for calculating low-density lipoprotein cholesterol values","volume":"9","author":"Chen","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0090","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0095","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.CIR.0000100560.46946.EA","volume":"108","author":"Luepker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0100","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/01.CIR.0000145615.33955.83","article-title":"Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region","volume":"110","author":"Patel","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/106002809202600913","article-title":"The triglyceride connection in atherosclerosis","volume":"26","author":"Geurian","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.clinbiochem.2004.03.008","article-title":"Validation of the friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population","volume":"37","author":"Tremblay","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2458-8-176","article-title":"High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the iranian urban population: Tehran lipid and glucose study","volume":"8","author":"Hadaegh","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.diabres.2006.12.001","article-title":"Prevalence of metabolic syndrome in iranian adult population, concordance between the idf with the atpiii and the who definitions","volume":"77","author":"Zabetian","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.numecd.2008.09.003","article-title":"Triglyceride\/hdl-cholesterol ratio is an independent predictor for coronary heart disease in a population of iranian men","volume":"19","author":"Hadaegh","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0135","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/oxfordjournals.eurheartj.a059642","article-title":"The intraindividual variability of fasting triglyceride\u2014a challenge for further standardization","volume":"11","author":"Brenner","year":"1990","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/oxfordjournals.aje.a113490","article-title":"Retest reliability of plasma cholesterol and triglyceride. The lipid research clinics prevalence study","volume":"116","author":"Jacobs","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0021-9150(93)90187-Y","article-title":"Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein b-100","volume":"104","author":"Abate","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0150","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002862","article-title":"Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three european countries","volume":"3","author":"Coloma","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0160","doi-asserted-by":"crossref","first-page":"e70421","DOI":"10.1371\/journal.pone.0070421","article-title":"Variation in the sodium-dependent vitamin c transporter 2 gene is associated with risk of acute coronary syndrome among women","volume":"8","author":"Dalgard","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0165","doi-asserted-by":"crossref","first-page":"e000077","DOI":"10.1161\/JAHA.112.000077","article-title":"Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women","volume":"2","author":"Pai","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.clinbiochem.2014.03.004_bb0170","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.2012.14306","article-title":"Association of race and sex with risk of incident acute coronary heart disease events","volume":"308","author":"Safford","year":"2012","journal-title":"JAMA"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:45:13Z","timestamp":1757864713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912014001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":34,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0009912014001179"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.03.004","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}